The high-profile trial of former Theranos CEO Elizabeth Holmes boils down to a single question: Did she cover up defects in her startup’s blood-testing technology to rip off investors while potentially endangering the lives of unwitting patients.
source https://www.seattletimes.com/business/explainer-why-elizabeth-holmes-trial-hinges-on-intent/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_technology
No comments:
Post a Comment